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those patients congenitally prone to it and is precipitated at an
earHer age as a result of pregnancy. It may no longer be
demonstrable after delivery, but is likely to manifest itself
again at a later age, when a tendency to excessive weight gain
occurs.
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'ACTIFED'-A CLINICAL IMPRESSIO
MORRIS HEl.MA T, M.B., CH.B., Cape Town, Member 01 the College 01 General Practitioners-Kaap de Goede Hoop
D-PSEUDOEPHEDRlNE
Action
d-Pseudoephedrine is an orally effective nasal decongestant
which takes effect 15 - 30 minutes after oral administra-
tion. The mucous membrane of the entire respiratory tract
is gently, but promptly, decongested through action on
sympathetic nerves and smooth muscle. With its simultane-
ous bronchodilating action, d-pseudoephedrine facilitates
free breathing by opening the airway from nostrils to alveoH.
The systemic route of administration obviates the use of
topical preparations, thereby protecting the deHcate in-
flamed nasal mucosa from additional trauma. Furthermore,
it gives desirable prophylaxis against middle-ear complica-
tions by reaching and decongesting the Eustachian tubes.
Nasal Decongestion
d-Pseudoephedrine restores patency of the'nasal passages
by shrinking the engorged'nasal mucosa and quickly eli-
minating tissue hyperaemia and oedema. 'Its dilator action
on the bronchioles, as well as its contracting action on the
mucous membrane of the nose, do not essentially differ in
potency from that of ephedrine'.2
Bronchodilation
In clinical use,2,S and in laboratory studies,4 -the broncho-
dilator action of pseudoephedrine appears to be quite marked.
Complementing the bronchodilating action, pseudoephe-
drine decongests the mucosa of the tracheobronchial tree. 2,s
Toxicity
In animal studies pseudoephedrine has been found to be
nearly 50% less toxic than ephedrine. The LD50 for mice
is 700 mg. per kg.
CASE REPORTS
Of 30 patients for whom I prescribed actifed, the majority re-
sponded favourably and could go a~out .t~e~r duties u.ndisturbed.
These patients suffered from allergIC rhInItIs, bronchIal .catarrh,
asthma, sinusitis, postnasal drip, hayfever and. Eu~tachlan-tube
blockage. Also, there were patients with chromc dl.sease of the
upper respiratory tract, where symptoms had persisted despite
operation or bombardment with antibiotics. My trial has now
continued for a period of just over a year, and I propose to deSCrIbe
in brief some patients for whom I have prescribed actifed.
Case J
European male aged 70 years: He had a history of sinus infec-
tion for 10 years,'and was treated with antibiotics and sinus punc-
ture with incomplete relief. His condition gradually developed
into a persistent bronchitis and bronchial catarrh as well as ?septlc
arthritis. Sensitivity tests were done against organisms from hIS
sputum, and so many antibiotics were use~ in an atte~!?t ~o
clear his upper respiratory tract that he developed mon~aslS.
The sinusitis and bronchitis persisted and eventually cortIsone
was tried as well. He was given actifed, 1 tablet twice daily, and
thereafter was found to be completely relieved of bronchial catarrh
and wheezing chest as well as postnasal drip. He still expectorates








Some years ago I described a series of cases under the title
'Asthma in young boys' in this Joumaf.l I then showed that
a combination of drugs, such as pseudoephedrine and an
antihistaminic, should have most beneficial effects if given
to asthma sufferers every night before going to sleep, pro-
vided it was done over long periods. Messrs. Burroughs
Wellcome and Co. Ltd., taking cognizance of my article,
informed me that they, too, had investigated the effect of
such a combination of drugs in patients in whom the upper'
respiratory tract was involved idiopathically, or through
allergy or infection.
The commercial name given to this combination of drugs
is 'actifed'. It contains 30 mg. of pseudoephedrine, and
1 .25 mg. of triprolidine hydrochloride which is a powerful
antihistaminic. The pseudoephedrine combination is
interesting; I find it is less toxic and has fewer side-effects
than ephedrine hydrochloride. Also it has shown less central
stimulation and vasopressor effect. I particularly wish to
give full details of this drug as found in the literature, because
I feel that it has not been sufficiently investigated and could
be of great benefit where. a substitute for ephedrine hydro-
chloride is sought, especially in view of the fact that it is
less toxic and has less side-effects.
Ephedrine contains two asymmetric carbon atoms and
therefore has 6 synthetic isomers, viz. I, d and dl ephedrine,
and I, d and dl pseudoephedrine.
Two of these also occur naturally-/-ephedrine and
d-pseudoephedrine-and the chemical difference between
them lies in the relation between the hydroxyl group on
the a- and the methylamino group on the ,B-carbon atom
of the side chain, the groups being close to each other in










d-Pseudoephedrine, the natural alkaloid, is used in actifed
because it is almost as potent, weight for weight, as ephe-
drine, but produces neither the same degree of central stimu-
lation nor the vasopressor effect. The 1949 British Pharma-
ceutical Codex states: 'd-Pseudoephedrine resembles ephe-
drine qualitatively, but its effects, particularly on the blood
pressure, bronchi and higher centres, are weaker. It is less
toxic and has fewer side effects'.
. ~
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that I tablet on alternate mornings is enough to ontrol his symp-
toms.
Case 2
European male, aged 49 years: He came from the Congo to
live in Sea Point, but experienced severe chest wheezing at night,
a painful dry cough and nasal blockage. During,the day he was
quite normal. He had never had any illness like this before, except
bronchitis 2 years previously. On examination he had typical
bronchospasm. At first it was necessary to give him an injection
of adrenaline, but I decided to give him actifed tablet, I twice
daily for 2 days and thereafter 3 times a day. With the exception
of slight drowsiness his symptoms were completel. relie ed.
Case 3
European male, aged 40 years: He complained of deafnes of
his left ear, which had wax in it, but despite syringing there was
no improvement. In addition he had an old-standing suppurative
otitis media of his right ear. I referred him to an ear, nose and
throat specialist who diagnosed a blocked left Eustachian tube.
He polirserized him without improvement. I decided to try actifed,
and within 5 days his Eustachian-tube deafness had completely
cleared up. In the patient's own words 'it simply was wonderful!'
Case 4
European male, aged 36 years: He consulted me in 1956 with
a diagno is of catarrh of the upper respiratory tract. Sensitivity
tests showed him to be sensitive to house dust and the pollen of
flowers. At this time he was using an adrenaline spray as well a
antihistaminics, but this treatment made him very tired and
depressed. He had moved from where he lived previously to Sea
Point. In addition he had developed a bronchospasm at night.
Funher treatment with antibiotics, an electric air filter and warmer
in his room, plus sprays and antihistamine did not relieve him.
I suggested that he should try actired, and for the past 6 months
he has continued to use it. It has helped him more than any
other treatment he has had up to date. He stated that he could
now sleep undisturbed at night and that his bronchospasm and
nasal blocka~e are definitely relieved.
Case 5
European girl, aged 8 years: She had had nasal disturbances
since she was 5 years old. She had a tonsillectomy, but this did
not improve matters. Sensitivity tests with antibiotics, inhalations
and breathing exercises were also tried, but they brought little
relief to the nasal disturbances. An X-ray revealed definite maxil-
lary-sinus involvement. It was necessary to have a sinus operation
performed, despite her age. There was some improvement, although
the child was troubled at school because her teacher continually
reprimanded her for blowing her nose. I prescribed actired for
her and found that her nasal disturbances were gradually con-
trolled by its use. Also, it helped to tide her over until she could
have a further operation to her sinuses, which have since cleared
up.
Case 6
European female, aged 20 years: She suffered from broncho-
pasm at night. Her symptOms were no e bl kage, light ough,
and a general tightne of her chest. Despite the use of 'amesec'
capsules, adrenaline inj lion and desen itization \ ith azopro-
tein, J was obliged eventually to pre cribe cortisone t relieve her
symptoms for 6 week. When the course of orti one \ a com-
pleted, her ymptom gradually came b ck. T fund that in pre-
ribing a tifed, in addition to a much maller dose of coni one
than formerly, I managed to ontrol her ymptom for th last
6 months.
Case 7
European male, aged 70 years (seen by Dr. J. onnenberg):
He tates that for the past 6 months his no e ju t ran ithout
warning. He al 0 developed broncho pasm. His no was caut r-
ized but this gave only temporary relief. On e amination he
appeared to have typical allergic rhinitis. He was gi en actifed,
1 tablet twice daily, with almost dramatic improvement.
co 'CLUSIO T
The 7 patient I have mentioned repre ent a fair cro -
section of my trial cases helped by actifed treatment. It is
not a cure except in ea onal ca es, but it is certainly a very
good preparation in the ymptomatic treatment of upper
respiratory condition, especially when a patient has been
through a long period of illne s with many different foml
of treatment and the doctor is rather at a 10 for omething
new. I have noticed no side-effect, except slight drowsine s
at the beginning of treatment. This passes off after a few
days' treatment.
I must point out that actifed i not a blunderbu s com-
bination, containing only pseudoephedrine and triprolidine.
If an antipyretic is nece sary, aspirin compound could be
given in addition.
Since this article was prepared, Burrough Wellcome have
brought out actifed tablets in half the trength used in thi
trial. This will do away with the drowsine and allow for
greater flexibility in dosage.
I wish to thank Pror. F. Forman, Prof. . apeika, and Dr.
I. Grayce for kindly reading this paper and for their useful com-
ments. I also wish to thank Burroughs WeLlcome and Co. (S.A.)
Ltd. for supplying the tablets used.
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SELF-RADIATION PRODUCTS FORMED FROM 3,5,3'-TRI-IODO-L-THYRONINE
LABELLED WITH131I*
A. VAN ZYL, Department of Physiology, Medical School, University of Cape TowlI
3,5,3'-tri-iodo-L-thyronine, labelled with 131I is used in our
laboratories mainly for two purposes, namely, for metabolic
studies and for red-cell uptake as an additional indicator of
thyroid activity.' Because of its marked influence on meta-
bolism, low concentrations of the thyroid hormone are required
for metabolic studies. This necessitates the preparation of
thyroid hormones of extremely high specific radioactivity. The
test for· red-celI uptake depends upon the affinity of red cells
for thyroid hormones. This affinity is less than that of the
serum proteins. As thyroid activity increases, increa cd con-
centration of circulating thyroid hormone causes saturation of
the binding protein in serum, and as a result more and more
• Ab tract of a paper presented at Re earch Forum, University of Cape
Town.
hormone is taken up by the red cell . Since red-cell uptake
therefore clearly depends on the concentration of the hormone,
a small concentration of the hormone with high radioactivity
i again required.
In South Africa we still depend largely on the import of
labelled horm')nes of high specific radioactivity. The e hor-
mones reach our laboratories, at the earlie t, 5 days after
production (day of production i taken as the day of determi-
nation of specifi activity) and sometime only a few day
before the expiry date (14 day after production). During
transport and torage, radiochemical decomposition fr m elf-
radiation' may occur. It i conceivable that the extent of
decomposition bear a relation hip to the pecific radioactivity.
